Introduction
============

The majority of antibiotics are poorly absorbed in animal gut, and significant amount of antibiotics is excreted into the environment through feces and urine ([@B4]). In China, manures are commonly applied to agricultural land to recycle their plant nutrients. The agricultural land has accumulated a statistically significant higher antibiotics concentration than conventional open croplands because the use of animal manure ([@B45]). In addition, it is well-known that different residual concentrations of ciprofloxacin have been found in manure-amended environment ([@B46]; [@B21]; [@B22]). For instance, ciprofloxacin had a higher detection frequency and maximum concentration in 20--60 cm soil layer than that in 0--20 cm soil layer ([@B38]). The potential of subinhibitory concentration of antibiotics to promote the development of antibiotic-resistance genes (ARGs) in complex bacterial communities ([@B3]). For example, even at levels that are considered safe according to the currently accepted Environmental Quality Standard, antibiotics can still select for ARGs ([@B24]; [@B17]; [@B30]).

Ciprofloxacin is the most widely used fluoroquinolone antibiotic ([@B26]) which is active against a broad spectrum of Gram-negative and Gram-positive bacteria ([@B7]), and it has been detected in various composts and manures ([@B44]). Some horizontally transferable elements might help account for the strong association between resistance to quinolones, such as plasmid-mediated quinolone resistance (PMQR) -- encoding genes ([@B32]). PMQR -- encoding genes have been found in the environment due to the selective pressure posed by fluoroquinolones ([@B5]). So far, PMQR has managed to achieve global distribution in a variety of plasmid environments and bacteria genera ([@B29]; [@B27]; [@B39]; [@B11]). Presently three types of PMQR-encoding genes have been identified and these correspond to the Qnr proteins encoded by *qnrA*, *qnrB*, *qnrC*, *qnrD* and *qnrS*, an aminoglycoside acetyltransferase variant capable of reducing ciprofloxacin activity encoded by *aac(6^′^)-Ib-cr* ([@B28]; [@B20]), and drug eﬄux pumps encoded by *qepA* and *oqxAB* ([@B14]). These mechanisms provide the low-level quinolone resistance to facilitate the emergence of higher-level resistance in the presence of quinolones ([@B29]). In studies of soil bacterial isolates, over 76% of the fluoroquinolones (levofloxacin and ciprofloxacin) resistance was shown to be mediated by eﬄux ([@B37]). Although, more studies focused on the effect of different classes of antibiotics as selective pressure on ARGs and resistant bacteria in soil containing manure ([@B16]; [@B8]; [@B34]), it is also important to explore the relationship between different antibiotic concentrations in the environment and bacterial taxa and PMQR-encoring genes.

The aim of the present study was to investigate the fate of PMQR-encoding genes and the abundance of soil bacterial communities posed by different concentrations of ciprofloxacin in manure applied to soil. To our knowledge, this is the first report to investigate the effect of different antibiotic residue levels on the dissipation rates of PMQR-encoding genes and bacterial taxa after manure application.

Materials and Methods {#s1}
=====================

Treatment
---------

Manure samples were collected from healthy mature ciprofloxacin-free swine was introduced into arable soils. The soils were collected from arable land which had no known exposure to antibiotics and had minimal human-induced selective pressure. Manure (60 g) was incorporated into 1500 g of 2 mm sieved soil (4%, w/w) with or without antibiotics and served as treatment and control groups, respectively ([@B16]). Three treatment groups each containing three replicates were set up as follows: 4 mg kg^-1^ ciprofloxacin (A), 0.4 mg kg^-1^ ciprofloxacin (B) and 0.04 mg kg^-1^ ciprofloxacin (C). The ciprofloxacin doses were selected for the current studies based on previous reports indicating the average concentration of ciprofloxacin was about 0.04--0.4 mg/kg in the soil environment ([@B22]; [@B42]). In addition, ciprofloxacin at 4 mg/kg is a standard dose for treatment in pigs ([@B25]). A control group lacking ciprofloxacin was designated group D. Pots containing the above mixtures were incubated at 20°C for 60 days in the dark. Water was added to the soil surface twice a week in order to maintain the soil moisture content at approximately 55% of the soil's water holding capacity. Soil samples were collected at days 0, 30, and 60 ([@B41]).

UPLC--MS/MS Determination
-------------------------

Soil samples (1 g) from different groups and time points as described above were freeze-dried at -80°C until usage. For sample processing, these were spiked with 5 ml extraction buffer containing equal proportions of acetonitrile/phosphate at pH 3.0. Solid phase extraction was conducted according to a previously published method ([@B23]). Ciprofloxacin concentrations were determined by ultra-performance liquid chromatography--electrospray tandem mass spectrometry (UPLC--MS/MS). Concentrated extracts were separated on an Agilent 1200 liquid chromatograph (Santa Clara, CA, USA) using a Waters Quattro Micro triple quadrupole mass spectrometer in multiple reactions monitoring mode with electrospray ionization in positive-ion mode (Milford, MA, USA).

DNA Extractions
---------------

DNA from soil samples was extracted using the Power Soil Kit (Mo Bio Laboratories, Inc., Carlsbad, CA, USA) according to the manufacturer's instructions. Total DNA was quantified using a NanoDrop^®^ ND-2000 UV spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). Only DNA samples with A260/A280 \> 1.7 and A260/A230 \> 1.8 were used for further analysis. The extracts were stored at -20°C until use.

Detection and Relative Quantification of ARGs
---------------------------------------------

Polymerase chain reaction (PCR) was used to screen the major PMQR genes *qnrA*, *qnrB*, *qnrC*, *qnrD*, *qnrS*, *qepA*, *aac(6^′^)-Ib-cr*, and *oqxA* as previously described ([@B33]). To ensure reproducibility, three replicate assays for each sample were performed in parallel with positive and negative controls in each run. PMQR and 16S rRNA genes were further quantified by real time qPCR using SYBR Premix Ex Taq (TAKARA Bio, Otsushi, Japan) in a Bio-Rad iQ5 thermal cycler according to the manufacturer's instructions (Hercules, CA, USA). A eubacterial 16S rRNA gene ([@B33]) was also quantified so that ARGs could be normalized to the total bacterial community. Cycling conditions were as follows: 94°C for 5 min followed by 35 cycles at 94°C for 1 min, 60°C for 1 min and 72°C for 1 min with a final extension at 72°C for 5 min. Melting curve analysis was performed for every assay from 60 to 95°C with 1°C intervals. Given the temporal variations caused by total bacterial community and overall extraction efficiencies, the copies of ARGs were normalized to the 16S rRNA gene copies (ARGs copies/16S rRNA gene copies, defined as relative abundance). All experiments were performed in triplicate and the standard error of the measurements was determined from these parallel data.

Total Bacteria Counts and Enumeration of Ciprofloxacin-Resistant (CIPr) Bacteria
--------------------------------------------------------------------------------

Colony-forming unit (CFU) counts of culturable bacteria recovered from soil were detected on Luria-Bertani (LB) agar. Soil samples (wet weight 5 g) were recovered in 45 ml of 0.9% NaCl by shaking at 120 rpm at 25°C for 1 h. Soil particles were then allowed to settle for approximately 15 min at room temperature. About 100 μL of serial 10-fold dilutions were plated on LB agar and incubated at 37°C for 3 days in triplicate. Plates containing 4 mg/L of ciprofloxacin were used to counted CIPr bacteria based on previous studies ([@B33]). The fraction of CIPr bacteria was calculated as the ratio of bacteria growing on plates supplemented with CIP to the number of bacteria growing on plates without CIP ([@B42]).

Amplicon Sequencing
-------------------

The V3+V4 ([@B1]; [@B19]) hypervariable regions of 16S rDNA was PCR amplified from microbial DNA harvested from three replications for four different groups at day 60. The PCR products from the three replications were pooled together in equimolar ratios for amplicon sequencing. The gene-specific sequences used the 16S V3 and V4 region, 341F 5^′^-CCTACGGGNGGCWGCAG-3^′^ and 805R 5^′^-GACTACHVGGGTATCTAATCC-3^′^ ([@B1]; [@B19]). The PCR conditions were as follows: one pre-denaturation cycle at 94°C for 4 min, 25 cycles of denaturation at 94°C for 30 s, annealing at 55°C for 45 s, and elongation at 72°C for 30 s, and one post-elongation cycle at 72°C for 5 min. The PCR amplicons were separated on 0.8% agarose gels and then extracted. Only PCR products without primer dimers and contaminant bands were used for sequencing. Amplicons were purified using AMPure X using the manufacturer's instructions (Beckman Coulter, Inc., Mississauga, ON, Canada). Bar-coded V3 and V4 amplicons were sequenced using the 2 × 300 paired-end method by Illumina MiSeq with a seven-cycle index read. Sequences processing was performed using QIIME (version 1.6.0) to get clean data. Sequences with an average Phred (Q) score lower than 30, with ambiguous bases or homopolymer runs exceeding 6 bp, primer mismatches or sequence lengths shorter than 100 bp were removed. The consensus sequence was generated by FLASH (Fast length Adjustment of Short reads, v1.2.11) as following: only sequences with an overlap longer than 10 bp and without any mismatch were assembled according to their overlap sequence. Reads that could not be assembled were discarded. Barcode and sequencing primers were trimmed from the assembled sequence. The high quality paired-end reads were combined to tags based on overlap. The tags were clustered to operational taxonomic unit (OTU) by software USEARCH (v7.0.1090). OTU representative sequences were taxonomically classified using Ribosomal Database Project (RDP) Classifier v2.2 trained on the Greengenes database.

Statistical Analyses
--------------------

Copies of PMQR-encoding genes were normalized (PMQR-encoding gene copies/16S rRNA gene copies) and log transformed for linear-regression analysis using SPSS 19.0. Significant differences of relative ARG abundance and resistant bacteria among different groups were analyzed by ANOVA and Bonferroni correction using SPSS 19.0. Differential abundance of bacterial taxa between different groups were compared using Fisher's exact test ([@B40]) at a statistical difference level of *p* \< 0.05 and Bonferroni correction.

Results
=======

Concentration of Ciprofloxacin
------------------------------

The residual concentration of ciprofloxacin in soil from all study groups at days 0, 30, and 60 are shown in **Table [1](#T1){ref-type="table"}**. A significant time and concentration-dependent ciprofloxacin residues were observed in all three ciprofloxacin treated groups, but as expected, not in the control group.

###### 

Ciprofloxacin concentrations at days 0, 30, and 60.

  Treatment group   Concentrations (μg kg^-1^)                    
  ----------------- ---------------------------- ---------------- ----------------
  A                 1331.34 ± 118.68             759.48 ± 21.61   502.66 ± 50.44
  B                 151.35 ± 16.50               103.92 ± 0.8     63.80 ± 1.56
  C                 21.48 ± 1.93                 15.32 ± 0.66     9.82 ± 0.46
  D                 ND                           ND               ND

ND, not detected.

Abundance of PMQR-Encoding Genes
--------------------------------

The relative abundances of three detectable PMQR genes \[*qnrS*, *oqxA*, and *aac(6^′^)-lb-cr*\] are showed in Supplementary Table [S1](#SM3){ref-type="supplementary-material"}. The current results showed that *qnrA*, *qnrB*, *qnrC*, *qnrD*, *qepA* were absent from all soil samples. At the day 60, the relative abundance of all detected PMQR-encoding genes in the treatment and control groups had significantly decreased as compared to day 0 (*p* \< 0.05). For instance, the relative abundance of *qnrS* gene was decreased 129% in the control group from day 0 to day 60 (**Figure [1](#F1){ref-type="fig"}**). On the other hand, ciprofloxacin at 4 mg/kg had significantly higher dissipated rate of relative abundance of the three PMQR genes as compared to the control group. Therefore, ciprofloxacin at 4 mg/kg group had the lowest abundance at day 60 vs. all other tested groups (Supplementary Table [S1](#SM3){ref-type="supplementary-material"}). However, ciprofloxacin at 0.4 and 0.04 mg/kg concentrations, the dissipate rate of relative abundances of *qnrS*, *oqxA*, and *aac(6^′^)-lb-cr* were the lowest as compared to the control and ciprofloxacin 4 mg/kg groups (**Figure [1](#F1){ref-type="fig"}**).

![**Variations in the relative abundance of PMQR-encoding genes at days 0, 30, and 60 following treatments.** Dissipation rates are expressed by the values on the arrows \[black for *qnrS*, red for *oqxA* and blue for *aac(6^′^)-Ib-cr*\].](fmicb-07-01730-g001){#F1}

Shifts in the Number of Resistant Bacteria with Different Treatments
--------------------------------------------------------------------

The proportion of bacterial communities resistant to ciprofloxacin in all study groups was similar (∼40%) at day 0, but decreased over 60 days (range from 42.66--46.06% to 14.67--29.93% for days 0 and 60, respectively) (**Supplementary Figure [S1](#SM1){ref-type="supplementary-material"}**). At days 30 and 60, ciprofloxacin-resistant bacteria communities in ciprofloxacin at 0.4 and 0.04 mg/kg groups were significantly higher than in ciprofloxacin at 4 mg/kg group, as well as the control group (*p* \< 0.05).

Bacteria Community Composition
------------------------------

A total of 155,697 reads of the V3--V4 regions of bacterial 16S rDNA genes were obtained from a total of four soil samples. The dominant classes were *Alphaproteobacteria* (35.08--38.11%), *Gammaproteobacteria* (13.49--17.21%) and *Saprospirae* (11.01--14.28%) in all soil samples (**Figure [2](#F2){ref-type="fig"}**). In addition, the population of *Alphaproteobacteria* was significantly decreased, while *Gammaproteobacteria* was significantly increased in all ciprofloxacin exposure groups as compared to the control group. Moreover, *Saprospirae* was significantly decreased only with ciprofloxacin exposure at the lower level of ciprofloxacin residue in soil treatment group (0.04 mg/kg) as compared to the control group (Supplementary Table [S2](#SM4){ref-type="supplementary-material"}).

Based on sequence identification, a further evaluation was performed focusing on bacterial that might be associated with pathogeneses and ciprofloxacin resistance. For example, *Agrobacterium*, which belongs to *Alphaproteobacteria*, and *Clostridium*, which belongs to *Clostridia*, were significantly decreased in the 4 and 0.4 mg/kg ciprofloxacin concentrations treatment as compared to the control group. In addition, the abundance of *Xanthomonadales, which* belongs to *Gammaproteobacteria*, *Bacillales, which* belongs to *Bacillales*, and *Burkholderia*, which belongs to *Betaproteobacteria*, were greater in the 0.04 mg/kg ciprofloxacin exposure group than the 0.4 and 4 mg/kg ciprofloxacin groups (Supplementary Table [S2](#SM4){ref-type="supplementary-material"}). Raw sequence were submitted to Sequence Read Archive database in NCBI (accession No. SAMN05575008, SAMN05575009, SAMN05575010, SAMN05575011).

![**Relative abundance of bacterial classes between different treatment groups. (A)** 4 mg kg^-1^ ciprofloxacin; **(B)** 0.4 mg kg^-1^ ciprofloxacin; **(C)** 0.04 mg kg^-1^ ciprofloxacin; **(D)** 0 mg kg^-1^, as control.](fmicb-07-01730-g002){#F2}

Discussion
==========

The concentration of antibiotic residues was observed to be significantly correlated with variations in the bacterial community. For example, a positive correlation was observed between the concentration of sulfamethoxazole and tetracycline and the classes *Bacteroidia* and *Gammaproteobacteria* ([@B35]). In our study, we found that the abundance of the bacteria in the lower level of ciprofloxacin residue in soil treatment group is significantly distinct from the standard dose of ciprofloxacin for treatment. For instance, *Actinobacteria*, *Bacilli*, *Clostridia* and *Gammaproteobacteria* enriched, while *Acidobacteria* and *Holophagae* were inhibited in the lower level of ciprofloxacin residue in soil treatment group vs. the standard dose of ciprofloxacin for treatment. In addition, the abundance of *Xanthomonadales*, *Bacillales, Burkholderia*, and *Agrobacterium* were greater in the lower level of ciprofloxacin residue in soil treatment group than other level of ciprofloxacin groups. Previous study reported that *Xanthomonadales*, *Burkholderia cepacia* and *Bacillales* were associated with intrinsic ciprofloxacin resistance ([@B10]; [@B37]). *Agrobacterium* can be responsible for opportunistic infections in humans with weakened immune systems ([@B9]; [@B18]). These results perhaps suggested that the low ciprofloxacin concentration in soil is benefit for emergence and enrichment of ciprofloxacin-resistant bacteria. On the other hand, our studies also demonstrated that opportunistic pathogens such as *Enterococcus* increased in the lower level of ciprofloxacin residue in soil treatment group as compared with other groups. These data suggest that lower concentrations of ciprofloxacin in soil may increase bacterial pathogenesis and cause a threat to both human and animal health.

Recent studies from other laboratories showed that the development of resistant bacteria can occur at sub-MIC levels of antibiotic exposure from sensitive bacterial strains ([@B13], [@B12]; [@B36]). According to Clinical and Laboratory Standards Institute guidelines ([@B6]), the MIC of sensitive *Pseudomonas aeruginosa*, *Acinetobacter* spp., *Staphylococcus* spp., *Enterococcus* spp., *Haemophilus influenzae*, and *Haemophilus parainfluenzae* are ≤1 μg/ml, the MIC of sensitive *Salmonella* spp. and *Neisseria gonorrhoeae* are ≤0.06 μg/ml, the MIC of sensitive *Neisseria meningitidi*s are ≤0.03 μg/ml, and the MIC of sensitive *Yersinia pestis* are ≤0.25 μg/ml. In our current studies, there were detectable increased in the proportion of bacteria cultured from 4 mg/L ciprofloxacin medium in the lower level of ciprofloxacin residue in soil treatment group as compared to the standard dose of ciprofloxacin for treatment. These observations are consistent with other report indicating that low antibiotic levels, which are present in many natural environments, are relevant for the enrichment and maintenance of pre-existing antimicrobial resistant bacteria ([@B2]; [@B13]).

Additionally, previous studies have suggested that manure bacteria might not be well-adapted to the soil environment and therefore may decrease in abundance after application ([@B15]). This outcome may depend on varying environmental conditions, such as temperature, oxygen, moisture, pH and the indigenous community present ([@B31]; [@B15]; [@B4]). For example, the numbers of tetracycline-resistant bacteria increased in soil at the time when the manure was added. However, these increased antibiotic-resistant bacteria declined after the cessation of slurry applications to a level of non-slurry fertilized soil within 8 months ([@B31]). In the current studies, we showed that the relative abundance of PMQR genes significantly dissipated at day 60 which is consistent with the above investigations in other laboratories ([@B31]; [@B15]; [@B4]). In addition, it has been reported that ciprofloxacin at approximately fivefold higher concentrations than its minimum detectable level in biosolid compost feedstock had no effect on the enrichment of CIPr genes ([@B43]). Our studies also showed that the abundance of PMQR genes dissipated faster in the standard dose of ciprofloxacin for treatment (dissipation rate 120.2--142.8%) vs. the low ciprofloxacin (dissipation rate 88.5--106.6%), suggesting that high ciprofiloxacin concentration had less influence on the enrichment of PMQR genes.

Conclusion
==========

Lower ciprofloxacin concentration incorporated into the soil treated with manure influenced not only the dissipation of PMQR genes, especially *qnrS*, *oqxA* and *aac (6^′^)-Ib-cr*, but also changed the bacterial taxa in the soil. The dissipation of PMQR genes in the presence of lower ciprofloxacin concentration was slower than with higher levels. Lower ciprofloxacin levels in the soil can provide a selective advantage for bacteria in orders including *Xanthomonadales* and *Bacillales* and genera including *Agrobacterium*, *Bacillus*, *Enterococcus*, and *Burkholderia*.
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**Cultivation-based estimation of the relative abundance of ciprofloxacin-resistant bacteria in all groups isolated from days 0, 30, and 60.** ^a,b^Significantly different (black for group A, red for group B, blue for group C, and green for group D).
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